A61P 23/00
Anaesthetics
A61P23/00 (Anaesthetics) appears on 2,036 US grants and 2,949 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,036
- Published applications
- 2,949
- Assignees
- 1,229
- Inventors
- 4,716
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 6 | 0 |
| 1989 | 8 | 0 |
| 1990 | 9 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 4 | 0 |
| 1996 | 38 | 0 |
| 1997 | 38 | 0 |
| 1998 | 38 | 0 |
| 1999 | 41 | 0 |
| 2000 | 35 | 0 |
| 2001 | 54 | 16 |
| 2002 | 55 | 53 |
| 2003 | 37 | 98 |
| 2004 | 39 | 123 |
| 2005 | 35 | 111 |
| 2006 | 37 | 111 |
| 2007 | 41 | 97 |
| 2008 | 34 | 120 |
| 2009 | 49 | 125 |
| 2010 | 60 | 155 |
| 2011 | 85 | 203 |
| 2012 | 108 | 204 |
| 2013 | 109 | 168 |
| 2014 | 140 | 155 |
| 2015 | 106 | 136 |
| 2016 | 103 | 123 |
| 2017 | 112 | 120 |
| 2018 | 73 | 105 |
| 2019 | 105 | 116 |
| 2020 | 83 | 122 |
| 2021 | 65 | 118 |
| 2022 | 62 | 99 |
| 2023 | 52 | 92 |
| 2024 | 62 | 83 |
| 2025 | 54 | 57 |
| 2026 | 16 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Topical anaesthetic composition having improved vasoconstrictor stability6 Oct 2026US 12,751,946 B2Animal Ethics Pty Ltd
- Long-acting ropivacaine pharmaceutical composition, preparation method therefor and use thereof29 Sep 2026US 12,746,286 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 218 Aug 2026US 12,709,605 B2Eth Zuerich
- Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disorders21 Jul 2026US 12,686,700 B2Sage Therapeutics, Inc.
- Aqueous patch23 Jun 2026US 12,661,327 B2Teikoku Seiyaku Co., Ltd.
- Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders8 Oct 2026US 2026/0308198 A1Sage Therapeutics, Inc.
- Pharmaceutical composition comprising ubiquinone-5 and method of use thereof24 Sep 2026US 2026/0283979 A1The Trustees of Columbia University in the City of New York
- Sustained release hydrogel composition10 Sep 2026US 2026/0263439 A1The Governing Council of the University of Toronto
- Local anesthetics with selective-sensory nerve blockade27 Aug 2026US 2026/0250249 A1Children's Medical Center Corporation
- Crystalline forms of a neuroactive steroid20 Aug 2026US 2026/0242410 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Non-adhesive elastic gelatin matrices1,357US 8,361,501 B2Covalon Technologies Inc. · 2013
- Element for implantation with medical device1,349US 8,092,443 B2Medtronic, Inc. · 2012
- Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine486US 10,299,720 B2The General Hospital Corporation · 2019
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Prolonged anesthesia in joints and body spaces209US 6,248,345 B1Euro-Celtique S. A. · 2001